ArticleFrontiers in oncology2024

Delayed neurotoxicity in HER2-positive breast cancer: a case series on combined SRS and T-DM1 treatment.

Menekse Turna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.